Nisa Investment Advisors
JANX icon

Nisa Investment Advisors’s Janux Therapeutics JANX Stock Holding History

Nisa Investment Advisors’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2K Buy
2,390
+970
+68% +$13.3K ﹤0.01% 1842
2025
Q4 		$19.6K Sell
1,420
-390
-22% -$9.17K ﹤0.01% 1951
2025
Q3 		$44.2K Buy
1,810
+40
+2% +$974 ﹤0.01% 1660
2025
Q2 		$40.9K Hold
1,770
– – ﹤0.01% 1646
2025
Q1 		$47.8K Sell
1,770
-10,097
-85% -$381K ﹤0.01% 1601
2024
Q4 		$635K Sell
11,867
-8,476
-42% -$448K ﹤0.01% 996
2024
Q3 		$924K Buy
20,343
+17,592
+639% +$765K 0.01% 877
2024
Q2 		$115K Buy
2,751
+18
+0.7% +$845 ﹤0.01% 1438
2024
Q1 		$103K Buy
2,733
+23
+0.8% +$501 ﹤0.01% 1455
2023
Q4 		$29.1K Buy
2,710
+2,685
+10,740% +$23.2K ﹤0.01% 1764
2023
Q3 		$252 Buy
+25
New +$288 ﹤0.01% 2636

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nisa Investment Advisors's JANX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Janux Therapeutics (JANX) stake by 68% in Q1 2026, buying an estimated $13.3K and bringing the position to 2,390 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

Nisa Investment Advisors first reported a position in JANX in Q3 2023 and has held it in 11 quarters since. The position peaked at $924K in Q3 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Nisa Investment Advisors held 2,390 shares of Janux Therapeutics worth $33.2K as of Q1 2026.
  • Nisa Investment Advisors bought 970 Janux Therapeutics shares in Q1 2026, an estimated $13.3K.
  • Janux Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1842 holding.
  • Nisa Investment Advisors first reported a position in Janux Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Janux Therapeutics position peaked at $924K in Q3 2024.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.